Trial Profile

Phase II Long-term Extension Study to Assess the Safety, Tolerability, and Efficacy of BI 730357 in Patients With Moderate-to-severe Plaque Psoriasis

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 21 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BI 730357 (Primary)
Indications Plaque psoriasis
Focus Adverse reactions
Sponsors Boehringer Ingelheim

Most Recent Events

27 Oct 2022 Status changed from completed to discontinued.
02 Aug 2021 Status changed from active, no longer recruiting to completed.
23 Jul 2021 Planned End Date changed from 19 Jul 2021 to 26 Jul 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com